These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 39355585)
1. Left Atrial Hemodynamics and Clinical Utility in Heart Failure. Lin CY; Lin SI; Lee YH; Chen CY Rev Cardiovasc Med; 2024 Sep; 25(9):325. PubMed ID: 39355585 [TBL] [Abstract][Full Text] [Related]
2. Novel approaches for left atrial pressure relief: Device-based monitoring and management in heart failure. Miyagi C; Kuroda T; Karimov JH; Fukamachi K Front Cardiovasc Med; 2022; 9():910957. PubMed ID: 36035901 [TBL] [Abstract][Full Text] [Related]
3. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I). Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010 [TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial. Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M; J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211 [TBL] [Abstract][Full Text] [Related]
5. Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II). Berry N; Mauri L; Feldman T; Komtebedde J; van Veldhuisen DJ; Solomon SD; Massaro JM; Shah SJ Am Heart J; 2020 Aug; 226():222-231. PubMed ID: 32629295 [TBL] [Abstract][Full Text] [Related]
6. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494 [TBL] [Abstract][Full Text] [Related]
7. The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure: Remote Left Atrial Pressure Monitoring. Perl L; Meerkin D; D'amario D; Avraham BB; Gal TB; Weitsman T; Hasin T; Ince H; Feickert S; D'ancona G; Schaefer U; Sievert H; Leyva F; Whinnett ZI; Di Mario C; Jonas M; Glikson M; Habib M; Caspi O; Koren O; Abraham WT; Kornowski R; Crea F; J Card Fail; 2022 Jun; 28(6):963-972. PubMed ID: 35041933 [TBL] [Abstract][Full Text] [Related]
8. Acute pressure overload of the right ventricle. Comparison of two models of right-left shunt. Pulmonary artery to left atrium and right atrium to left atrium: experimental study. Argiriou M; Mikroulis D; Sakellaridis T; Didilis V; Papalois A; Bougioukas G J Cardiothorac Surg; 2011 Oct; 6():143. PubMed ID: 22011551 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ; Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial). Hanff TC; Kaye DM; Hayward CS; Post MC; Malek F; Hasenfuβ G; Gustafsson F; Burkhoff D; Shah SJ; Litwin SE; Kahwash R; Hummel SL; Borlaug BA; Solomon SD; Lam CSP; Komtebedde J; Silvestry FE; Am J Cardiol; 2019 Dec; 124(12):1912-1917. PubMed ID: 31653352 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter Implantable Devices to Monitoring of Elevated Left Atrial Pressures in Patients with Chronic Heart Failure. De Rosa R; Piscione F; Schranz D; Citro R; Iesu S; Galasso G Transl Med UniSa; 2017 Jul; 17():19-21. PubMed ID: 30050876 [TBL] [Abstract][Full Text] [Related]
14. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure. De Rosa R; Schranz D Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205 [TBL] [Abstract][Full Text] [Related]
15. Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR-HF trial. D'Amario D; Meerkin D; Restivo A; Ince H; Sievert H; Wiese A; Schaefer U; Trani C; Bayes-Genis A; Leyva F; Whinnett ZI; Di Mario C; Jonas M; Manhal H; Amat-Santos IJ; Del Trigo M; Gal TB; Avraham BB; Hasin T; Feickert S; D'Ancona G; Altisent OA; Koren O; Caspi O; Abraham WT; Crea F; Anker SD; Kornowski R; Perl L; Eur J Heart Fail; 2023 Jun; 25(6):902-911. PubMed ID: 37092287 [TBL] [Abstract][Full Text] [Related]
16. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646 [TBL] [Abstract][Full Text] [Related]
17. Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction. Litwin SE; Komtebedde J; Hu M; Burkhoff D; Hasenfuß G; Borlaug BA; Solomon SD; Zile MR; Mohan RC; Khawash R; Sverdlov AL; Fail P; Chung ES; Kaye DM; Blair J; Eicher JC; Hummel SL; Zirlik A; Westenfeld R; Hayward C; Gorter TM; Demers C; Shetty R; Lewis G; Starling RC; Patel S; Gupta DK; Morsli H; Penicka M; Cikes M; Gustafsson F; Silvestry FE; Rowin EJ; Cutlip DE; Leon MB; Kitzman DW; Kleber FX; Shah SJ; JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1103-1117. PubMed ID: 36939661 [TBL] [Abstract][Full Text] [Related]
18. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489 [TBL] [Abstract][Full Text] [Related]
19. Heart failure and atrial fibrillation in patients with an interatrial shunt. Park JJ; Cho GY; Choi W; Hwang IC; Kim JY; Yoon Y; Yoon CH; Kim BJ; Han MK; Bae HJ Clin Res Cardiol; 2021 Aug; 110(8):1270-1279. PubMed ID: 33649885 [TBL] [Abstract][Full Text] [Related]
20. 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II. Gustafsson F; Petrie MC; Komtebedde J; Swarup V; Winkler S; Hasenfuß G; Borlaug BA; Mohan RC; Flaherty JD; Sverdlov AL; Fail PS; Chung ES; Lurz P; Lilly S; Kaye DM; Cleland JGF; Cikes M; Leon MB; Cutlip DE; van Veldhuisen DJ; Solomon SD; Shah SJ JACC Heart Fail; 2024 Aug; 12(8):1425-1438. PubMed ID: 38934964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]